STALEY CAPITAL ADVISERS’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.9M Sell
273,722
-5,456
-2% -$1.27M 2.83% 11
2025
Q4
$57.8M Sell
279,178
-3,275
-1% -$648K 2.38% 13
2025
Q3
$52.4M Buy
282,453
+251
+0.1% +$43K 2.15% 17
2025
Q2
$43.1M Sell
282,202
-11,510
-4% -$1.77M 1.83% 18
2025
Q1
$48.7M Sell
293,712
-2,855
-1% -$447K 2.2% 16
2024
Q4
$42.9M Sell
296,567
-5,095
-2% -$790K 1.9% 18
2024
Q3
$48.9M Buy
301,662
+484
+0.2% +$77.1K 2.18% 16
2024
Q2
$44M Buy
301,178
+10,519
+4% +$1.56M 2.02% 17
2024
Q1
$46M Buy
290,659
+2,009
+0.7% +$320K 2.15% 15
2023
Q4
$45.2M Buy
288,650
+7,855
+3% +$1.2M 2.25% 15
2023
Q3
$43.7M Buy
280,795
+6,454
+2% +$1.06M 2.41% 14
2023
Q2
$45.4M Buy
274,341
+3,444
+1% +$556K 2.44% 15
2023
Q1
$42M Buy
270,897
+22,265
+9% +$3.6M 2.35% 17
2022
Q4
$43.9M Sell
248,632
-908
-0.4% -$157K 2.62% 13
2022
Q3
$40.8M Buy
249,540
+2,283
+0.9% +$386K 2.6% 11
2022
Q2
$43.9M Sell
247,257
-4,506
-2% -$803K 2.6% 11
2022
Q1
$44.6M Buy
251,763
+1,500
+0.6% +$255K 2.25% 15
2021
Q4
$42.8M Sell
250,263
-3,203
-1% -$524K 2.05% 17
2021
Q3
$40.9M Sell
253,466
-4,427
-2% -$755K 2.2% 16
2021
Q2
$42.5M Buy
257,893
+794
+0.3% +$131K 2.22% 15
2021
Q1
$42.3M Buy
257,099
+16,739
+7% +$2.71M 2.35% 16
2020
Q4
$37.8M Buy
240,360
+9,412
+4% +$1.39M 2.31% 15
2020
Q3
$34.4M Sell
230,948
-6,432
-3% -$952K 2.38% 14
2020
Q2
$33.4M Sell
237,380
-1,510
-0.6% -$220K 2.42% 13
2020
Q1
$31.3M Buy
238,890
+1,467
+0.6% +$208K 2.63% 10
2019
Q4
$34.6M Buy
237,423
+6,825
+3% +$926K 2.35% 15
2019
Q3
$29.8M Buy
230,598
+3,307
+1% +$436K 2.24% 15
2019
Q2
$31.7M Sell
227,291
-269
-0.1% -$37.2K 2.36% 15
2019
Q1
$31.8M Buy
227,560
+1,081
+0.5% +$145K 2.35% 16
2018
Q4
$29.2M Sell
226,479
-369
-0.2% -$51.5K 2.37% 15
2018
Q3
$31.3M Buy
226,848
+2,621
+1% +$348K 2.19% 16
2018
Q2
$27.2M Buy
224,227
+20,461
+10% +$2.55M 2.09% 17
2018
Q1
$26.1M Buy
203,766
+5,813
+3% +$786K 2.05% 21
2017
Q4
$27.7M Sell
197,953
-49
-0% -$6.83K 2.15% 18
2017
Q3
$25.7M Sell
198,002
-4,199
-2% -$557K 2.1% 18
2017
Q2
$26.7M Buy
202,201
+185
+0.1% +$23.6K 2.28% 17
2017
Q1
$25.2M Buy
202,016
+7,111
+4% +$849K 2.25% 16
2016
Q4
$22.5M Buy
194,905
+5,651
+3% +$653K 2.16% 17
2016
Q3
$22.4M Sell
189,254
-485
-0.3% -$58.8K 2.23% 18
2016
Q2
$23M Sell
189,739
-880
-0.5% -$100K 2.41% 15
2016
Q1
$20.6M Buy
190,619
+10,196
+6% +$1.06M 2.23% 18
2015
Q4
$18.5M Sell
180,423
-399
-0.2% -$40.1K 2.14% 20
2015
Q3
$16.9M Buy
180,822
+39,690
+28% +$3.84M 2.05% 20
2015
Q2
$13.8M Buy
141,132
+6,001
+4% +$601K 1.53% 26
2015
Q1
$13.6M Buy
135,131
+20,250
+18% +$2.06M 1.57% 28
2014
Q4
$12M Buy
114,881
+4,730
+4% +$498K 1.4% 31
2014
Q3
$11.7M Buy
110,151
+831
+0.8% +$86.2K 1.4% 31
2014
Q2
$11.4M Sell
109,320
-507
-0.5% -$51.2K 1.37% 30
2014
Q1
$10.8M Buy
109,827
+682
+0.6% +$63.2K 1.37% 29
2013
Q4
$10M Sell
109,145
-724
-0.7% -$66.7K 1.36% 28
2013
Q3
$9.53M Buy
109,869
+828
+0.8% +$74.3K 1.45% 28
2013
Q2
$9.36M Buy
+109,041
New +$9.25M 1.51% 26

Other funds holding JNJ

STALEY CAPITAL ADVISERS's JNJ Position: Q1 2026 in Review

STALEY CAPITAL ADVISERS reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $1.27M and leaving 273,722 shares worth $66.9M. The position accounts for 2.83% of the portfolio, ranked #11.

STALEY CAPITAL ADVISERS first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • STALEY CAPITAL ADVISERS held 273,722 shares of Johnson & Johnson worth $66.9M as of Q1 2026.
  • STALEY CAPITAL ADVISERS sold 5,456 Johnson & Johnson shares in Q1 2026, an estimated $1.27M.
  • Johnson & Johnson made up 2.83% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #11 holding.
  • STALEY CAPITAL ADVISERS first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.